Form 4 Liquidia Technologies Inc For: 8 July
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Liquidia Technologies Inc (LQDA)
Liquidia Technologies Inc stock price live, this page displays NASDAQ LQDA stock exchange data. View the LQDA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Liquidia Technologies Inc real time stock price chart below.
What Is the Liquidia Technologies Inc Stock Price Today?
The Liquidia Technologies Inc stock price today is 77.930.
What Is the Stock Symbol for Liquidia Technologies Inc?
The stock symbol for Liquidia Technologies Inc is "LQDA."
What Stock Exchange Does Liquidia Technologies Inc Trade On?
Liquidia Technologies Inc is listed and trades on the NASDAQ stock exchange.
Is Liquidia Technologies Inc a Good Stock to Buy?
Determining whether Liquidia Technologies Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LQDA quote. (ISIN: US53635D2027)
What Is the Liquidia Technologies Inc Stock Price Today?
The Liquidia Technologies Inc stock price today is 77.930.
What Is the Stock Symbol for Liquidia Technologies Inc?
The stock symbol for Liquidia Technologies Inc is "LQDA."
What Stock Exchange Does Liquidia Technologies Inc Trade On?
Liquidia Technologies Inc is listed and trades on the NASDAQ stock exchange.
Is Liquidia Technologies Inc a Good Stock to Buy?
Determining whether Liquidia Technologies Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LQDA quote. (ISIN: US53635D2027)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
76.150
80.825
52 wk Range
13.760
82.960
LQDA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
76.15080.825
52 wk Range
13.76082.960
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LQDA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
74.250
Downside
-4.72%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
- Form 4 Liquidia Technologies Inc For: 24 June
- Investing.com
- Form 4 Liquidia Technologies Inc For: 8 July
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
Analyst Ratings
7 Buy
1 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 74.250
(-4.72% Downside)
Liquidia Technologies Inc Earnings Call Summary for Q1/2026
- Liquidia Q1 2026 EPS of $0.52 beat estimates by 40.54%; revenue of $132.86M exceeded forecasts by 13.93%, driving 4.25% premarket stock gain.
- YUTREPIA sales surged 44% sequentially, capturing 23% market share in inhaled prostacyclins; net income jumped 262% quarter-over-quarter to $52.9M.
- Non-GAAP adjusted EBITDA reached $71.2M, up 161% from Q4 2025, reflecting strong operational efficiency and market penetration success.
- CEO Neal Fowler highlighted sustained profitability with plans to expand manufacturing capacity and advance clinical programs for continued growth.
- Company projects further market share expansion despite competitive pressures, regulatory challenges, and potential saturation in inhaled prostacyclin segment.
Last Updated: 2026-05-11, 09:34 a/m
Read Full TranscriptEarnings
Latest Release
May 11, 2026
EPS / Forecast
0.52 / 0.37
Revenue / Forecast
132.86M / 116.62M
Compare LQDA to Peers and Sector
Metrics to compare | LQDA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLQDAPeersSector | |
|---|---|---|---|---|
P/E Ratio | 310.7x | −10.4x | −0.4x | |
PEG Ratio | 2.84 | −1.94 | 0.00 | |
Price/Book | 63.8x | 2.5x | 2.6x | |
Price / LTM Sales | 24.1x | 7.1x | 3.0x | |
Upside (Analyst Target) | −13.4% | 23.2% | 51.9% | |
Fair Value Upside | Unlock | 9.1% | 9.1% | Unlock |
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company’s lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also provides Remodulin, a treprostinil injection administered through continuous intravenous and subcutaneous infusion; and develops L606, an investigational liposomal formulation of treprostinil which is in phase III clinical trial for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). In addition, the company offers PRINT technology which allows to engineer and manufacture uniform drug particles with precise control over the size, three-dimensional geometric shape, and chemical composition of the particles. It has a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD; Vectura; The University of North Carolina at Chapel Hill; GlaxoSmithKline; Alcon Inc; and promotion Agreement with Sandoz. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Liquidia Technologies (LQDA) Stock Price Today?
The Liquidia Technologies stock price today is 77.930 USD.
What Stock Exchange Does Liquidia Technologies Trade On?
Liquidia Technologies is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Liquidia Technologies?
The stock symbol for Liquidia Technologies is "LQDA."
What Is the Liquidia Technologies Market Cap?
As of today, Liquidia Technologies market cap is 6.900B USD.
What Is Liquidia Technologies's Earnings Per Share (TTM)?
The Liquidia Technologies EPS (TTM) is 0.244.
When Is the Next Liquidia Technologies Earnings Date?
Liquidia Technologies will release its next earnings report on Aug 06, 2026.
From a Technical Analysis Perspective, Is LQDA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Liquidia Technologies Stock Split?
Liquidia Technologies has split 0 times.
How Many Employees Does Liquidia Technologies Have?
Liquidia Technologies has 216 employees.
What is the current trading status of Liquidia Technologies (LQDA)?
As of Jul 10, 2026, Liquidia Technologies (LQDA) is trading at a price of 77.930 USD, with a previous close of 81.450 USD. The stock has fluctuated within a day range of 76.150 USD to 80.825 USD, while its 52-week range spans from 13.760 USD to 82.960 USD.
What Is Liquidia Technologies (LQDA) Price Target According to Analysts?
The average 12-month price target for Liquidia Technologies is 74.250 USD, with a high estimate of 109 USD and a low estimate of 60 USD. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an -4.72% Downside potential.
What Is the LQDA Premarket Price?
LQDA's last pre-market stock price is 81.890 USD. The pre-market share volume is 1,110.000, and the stock has decreased by 0.440, or 0.540%.
What Is the LQDA After Hours Price?
LQDA's last after hours stock price is 77.330 USD, the stock has decreased by -0.600, or -0.770%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.